3-part Study to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Multiple Doses of CC-220 and Relative Bioavailability of a Formulated CC-220 Capsule
Clinical trial NCT02034773 · COMPLETED
Trial details
- NCT number
- NCT02034773
- Sponsor
- Celgene Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2013-12-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.